methenamine has been researched along with Prostatic Hyperplasia in 3 studies
Methenamine: An anti-infective agent most commonly used in the treatment of urinary tract infections. Its anti-infective action derives from the slow release of formaldehyde by hydrolysis at acidic pH. (From Martindale, The Extra Pharmacopoeia, 30th ed, p173)
hexamethylenetetramine : A polycyclic cage that is adamantane in which the carbon atoms at positions 1, 3, 5 and 7 are replaced by nitrogen atoms.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Olsen, JH | 1 |
Friis-Møller, A | 1 |
Jensen, SK | 1 |
Korner, B | 1 |
Hvidt, V | 1 |
Luna-Moré, S | 1 |
Genster, HG | 1 |
Madsen, PO | 1 |
1 trial available for methenamine and Prostatic Hyperplasia
Article | Year |
---|---|
Cefotaxime for prevention of infectious complications in bacteriuric men undergoing transurethral prostatic resection. A controlled comparison with methenamine.
Topics: Aged; Cefotaxime; Clinical Trials as Topic; Hippurates; Humans; Male; Methenamine; Middle Aged; Post | 1983 |
2 other studies available for methenamine and Prostatic Hyperplasia
Article | Year |
---|---|
Argyrophil crystalloids in adenocarcinoma of the prostate.
Topics: Adenocarcinoma; Aged; Alcian Blue; Amylases; Carcinoma in Situ; Eosine Yellowish-(YS); Hematoxylin; | 1993 |
Urinary tract infections following transurethral prostatectomy: with special reference to the use of antimicrobials.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteria; Bacteriuria; Ceph | 1970 |